Evidence map›Paper›PMID 41027713›Full record

ArticleRNA (New York, N.Y.)2025

New mechanistic insights into prespliceosome formation-roles of DEAD-box proteins Prp5 and Sub2.

Ching-Yang Kao, Wei-Yu Tsai, Yu-Lun Su, Che-Sheng Chung, Soo-Chen Cheng

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ching-Yang Kao *Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China.
Wei-Yu Tsai *Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China.
Yu-Lun SuInstitute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China.
Che-Sheng ChungInstitute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China.
Soo-Chen ChengInstitute of Molecular Biology, Academia Sinica, Taipei, Taiwan 115, Republic of China mbscc@ccvax.sinica.edu.tw.ORCID 0000-0002-7570-9415

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spliceosome is a highly dynamic structure that undergoes continuous structural alterations through the sequential association and dissociation of small nuclear RNAs and protein factors during precursor mRNA splicing. These structural changes are driven by eight DExD/H-box RNA helicases that act at distinct stages of the splicing cycle. Among them, Prp5 and Sub2 are involved in prespliceosome formation, with Prp5 implicated in displacing the U2 snRNP component Cus2, and Sub2 in facilitating the release of the Msl5-Mud2 heterodimer. However, the precise mechanisms underlying the functions of these two proteins remain unclear. Here, we show that Sub2 is not essential for splicing in vitro, but it can enhance splicing independently of ATP. Strikingly, prespliceosome formation can proceed without ATP in the absence of either Sub2 or Cus2. These findings reveal a coordinated interplay among Prp5, Sub2, Cus2 Mud2, and Msl5 during prespliceosome formation.

Indexed as

DEAD-box RNA HelicasesRNA SplicingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSpliceosomesAdenosine TriphosphateRNA Splicing FactorsAdenosine TriphosphateDEAD-box RNA HelicasesRNA Splicing FactorsSaccharomyces cerevisiae ProteinsATP-dependencyprespliceosomePrp5splicingSub2

Identifiers

PMID41027713
PMCPMC12621592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.